Literature DB >> 31972245

The amino-terminal region of dense granule protein 6 of Toxoplasma gondii stimulates IFN-γ production by microglia.

Qila Sa1, Corinne Mercier2, Marie-France Cesbron-Delauw2, Yasuhiro Suzuki3.   

Abstract

We examined activities of dense granule proteins (GRAs), which Toxoplasma gondii secretes within infected cells, to stimulate microglial IFN-γ production in vitro. We identified that the N-terminal region (amino acids 41-152) of GRA6 (GRA6Nt) stimulates IFN-γ production by both a microglia cell line and primary microglia purified from the brains of uninfected adult mice. In contrast, neither of GRA1, GRA2, GRA5Nt, nor the carboxyl-terminal (amino acids 174-224) of GRA6 stimulated microglial IFN-γ production. GRA6Nt appears to be a target molecule of the sentinel function of microglia to detect cerebral proliferation of T. gondii and activate their IFN-γ production for facilitating the protective immunity to control the pathogen.
Copyright © 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Dense granule protein 6; IFN-gamma; Innate immunity; Microglia; Protective immunity; Toxoplasma

Mesh:

Substances:

Year:  2020        PMID: 31972245      PMCID: PMC7369247          DOI: 10.1016/j.micinf.2019.12.003

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  19 in total

1.  Microglia and macrophages as innate producers of interferon-gamma in the brain following infection with Toxoplasma gondii.

Authors:  Yasuhiro Suzuki; Jennifer Claflin; Xisheng Wang; Andrea Lengi; Takane Kikuchi
Journal:  Int J Parasitol       Date:  2004-12-08       Impact factor: 3.981

Review 2.  Toxoplasma secretory granules: one population or more?

Authors:  Corinne Mercier; Marie-France Cesbron-Delauw
Journal:  Trends Parasitol       Date:  2015-01-15

3.  Limited value of assays using detection of immunoglobulin G antibodies to the two recombinant dense granule antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for distinguishing between acute and chronic infections in pregnant women.

Authors:  Josette Ferrandiz; Corinne Mercier; Martine Wallon; Stéphane Picot; Marie-France Cesbron-Delauw; François Peyron
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

4.  Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines.

Authors:  Filomena O Dimayuga; Janelle L Reed; Genevieve A Carnero; Chunmei Wang; Edgardo R Dimayuga; Vanessa M Dimayuga; Andrea Perger; Melinda E Wilson; Jeffrey N Keller; Annadora J Bruce-Keller
Journal:  J Neuroimmunol       Date:  2005-04       Impact factor: 3.478

5.  Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease.

Authors:  D K Howe; L D Sibley
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

6.  Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.

Authors:  R Gazzinelli; Y Xu; S Hieny; A Cheever; A Sher
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

7.  Interferon-gamma produced by microglia and the neuropeptide PACAP have opposite effects on the viability of neural progenitor cells.

Authors:  Johanna Mäkelä; Raili Koivuniemi; Laura Korhonen; Dan Lindholm
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

8.  Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease.

Authors:  Xisheng Wang; Hoil Kang; Takane Kikuchi; Yasuhiro Suzuki
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Microglia produce IFN-gamma independently from T cells during acute toxoplasmosis in the brain.

Authors:  Xisheng Wang; Yasuhiro Suzuki
Journal:  J Interferon Cytokine Res       Date:  2007-07       Impact factor: 2.607

10.  Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.

Authors:  Majid Golkar; Mohammad-Ali Shokrgozar; Sima Rafati; Karine Musset; Mehdi Assmar; Reza Sadaie; Marie-France Cesbron-Delauw; Corinne Mercier
Journal:  Vaccine       Date:  2007-03-09       Impact factor: 3.641

View more
  1 in total

Review 1.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.